Frequent glucose monitoring is recommended for patients treated with insulin – all patients with type 1 diabetes mellitus (T1D) and some patients with type 2 diabetes mellitus (T2D) - so they can adjust insulin dose, depending on factors such as diet and exercise [10]. The gene discussed is INS; the disease is type 2 diabetes mellitus.